EXPLORE!

Covaxin Taken Off Clinical Trial Mode

  768 Views

eMediNexus    12 March 2021

Bharat Biotechs indigenous COVID-19 vaccine, named Covaxin, has been taken off the clinical trial mode. Beneficiaries are not required to sign consent forms before taking the vaccine now. 

The decision comes a day after a subject expert committee made a recommendation in this regard to the DCGI. The ongoing phase 3 clinical trial has to be continued as per the approved protocol, stated the drug regulator. On March 4, Bharat Biotech had announced that the vaccine is 81% effective in preventing COVID-19 and can work against the UK variant. While the condition of use of the vaccine in clinical trial mode has been omitted, it will continue to be used under restricted use in emergency situation condition… (NDTV, March 11, 2021)

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.